Egis sees 4-6 pct revenue growth in 2012/13
BUDAPEST (Reuters) – Hungarian drugmaker Egis expects revenues to rise by 4-6 percent at constant currencies in the year to October 2013 as strong growth in the Commonwealth of Independent States (CIS) and Russia offsets falling sales at home.
Read more on Reuters











